|
1
|
Baborie A, Griffiths TD, Jaros E, McKeith
IG, Burn DJ, Richardson A, Ferrari R, Moreno J, Momeni P, Duplessis
D, et al: Pathological correlates of frontotemporal lobar
degeneration in the elderly. Acta Neuropathol. 121:365–371. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Seilhean D, Bielle F, Plu I and Duyckaerts
C: Frontotemporal lobar degeneration: Diversity of FTLD lesions.
Rev Neurol (Paris). 169:786–792. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shinagawa S: Phenotypic variety in the
presentation of frontotemporal lobar degeneration. Int Rev
Psychiatry. 25:138–144. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kaye ED, Petrovic-Poljak A, Verhoeff NP
and Freedman M: Frontotemporal dementia and pharmacologic
interventions. J Neuropsychiatry Clin Neurosci. 22:19–29. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Danysz W and Parsons CG: Alzheimer's
disease, β-amyloid, glutamate, NMDA receptors and memantine -
searching for the connections. Br J Pharmacol. 167:324–352. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kalia LV, Kalia SK and Salter MW: NMDA
receptors in clinical neurology: Excitatory times ahead. Lancet
Neurol. 7:742–755. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cummings JL, Schneider E, Tariot PN and
Graham SM: Memantine MEM-MD-SG-02 Study group: Behavioral effects
of memantine in Alzheimer disease patients receiving donepezil
treatment. Neurology. 67:57–63. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peng D, Yuan X and Zhu R: Memantine
hydrochloride in the treatment of dementia subtypes. J Clin
Neurosci. 20:1482–1485. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stubendorff K, Larsson V, Ballard C,
Minthon L, Aarsland D and Londos E: Treatment effect of memantine
on survival in dementia with Lewy bodies and Parkinson's disease
with dementia: A prospective study. BMJ Open. 4:e0051582014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lipton SA: Paradigm shift in
neuroprotection by NMDA receptor blockade: Memantine and beyond.
Nat Rev Drug Discov. 5:160–170. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Swanberg MM: Memantine for behavioral
disturbances in frontotemporal dementia: A case series. Alzheimer
Dis Assoc Disord. 21:164–166. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Boxer AL, Lipton AM, Womack K, Merrilees
J, Neuhaus J, Pavlic D, Gandhi A, Red D, Martin-Cook K, Svetlik D
and Miller BL: An open-label study of memantine treatment in 3
subtypes of frontotemporal lobar degeneration. Alzheimer Dis Assoc
Disord. 23:211–217. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Links KA, Black SE, Graff-Guerrero A,
Wilson AA, Houle S, Pollock BG and Chow TW: A case of apathy due to
frontotemporal dementia responsive to memantine. Neurocase.
19:256–261. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chow TW, Graff-Guerrero A, Verhoeff NP,
Binns MA, Tang-Wai DF, Freedman M, Masellis M, Black SE, Wilson AA,
Houle S and Pollock BG: Open-label study of the short-term effects
of memantine on FDG-PET in frontotemporal dementia. Neuropsychiatr
Dis Treat. 7:415–424. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chow TW, Fam D, Graff-Guerrero A, Verhoeff
NP, Tang-Wai DF, Masellis M, Black SE, Wilson AA, Houle S and
Pollock BG: Fluorodeoxyglucose positron emission tomography in
semantic dementia after 6 months of memantine: An open-label pilot
study. Int J Geriatr Psychiatry. 28:319–325. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Boxer AL, Knopman DS, Kaufer DI, Grossman
M, Onyike C, Graf-Radford N, Mendez M, Kerwin D, Lerner A, Wu CK,
et al: Memantine in patients with frontotemporal lobar
degeneration: A multicentre, randomised, double-blind,
placebo-controlled trial. Lancet Neurol. 12:149–156. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hodges JR: Hope abandoned: Memantine
therapy in frontotemporal dementia. Lancet Neurol. 12:121–123.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bird T, Knopman D, VanSwieten J, Rosso S,
Feldman H, Tanabe H, Graff-Raford N, Geschwind D, Verpillat P and
Hutton M: Epidemiology and genetics of frontotemporal
dementia/Pick's disease. Ann Neurol. 54(Suppl 5): S29–S31. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rascovsky K, Salmon DP, Lipton AM,
Leverenz JB, DeCarli C, Jagust WJ, Clark CM, Mendez MF, Tang-Wai
DF, Graff-Radford NR and Galasko D: Rate of progression differs in
frontotemporal dementia and Alzheimer disease. Neurology.
65:397–403. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boxer AL, Gold M, Huey E, Hu WT, Rosen H,
Kramer J, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, et al: The
advantages of frontotemporal degeneration drug development (part 2
of frontotemporal degeneration: the next therapeutic frontier).
Alzheimers Dement. Oct 10–2012.(Epub ahead of print)
doi:10.1016/j.jalz.2012.03.003. PubMed/NCBI
|
|
21
|
Riedl L, Mackenzie IR, Förstl H, Kurz A
and Diehl-Schmid J: Frontotemporal lobar degeneration: current
perspectives. Neuropsychiatr Dis Treat. Feb 13–2014.(Epub ahead of
print) doi:10.2147/NDT.S38706. PubMed/NCBI
|
|
22
|
Neary D, Snowden JS, Gustafson L, Passant
U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, et
al: Frontotemporal lobar degeneration: A consensus on clinical
diagnostic criteria. Neurology. 51:1546–1554. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rascovsky K, Hodges JR, Knopman D, Mendez
MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG,
Onyike CU, et al: Sensitivity of revised diagnostic criteria for
the behavioural variant of frontotemporal dementia. Brain. 134(Pt
9): 2456–2477. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang T, Xiao S, Li X, Wang H, Liu Y, Su N
and Fang Y: Reliability and validity of the Chinese version of the
neuropsychiatric inventory in mainland China. Int J Geriatr
Psychiatry. 27:539–544. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Freitas S, Simões MR, Alves L, Duro D and
Santana I: Montreal Cognitive Assessment (MoCA): Validation study
for frontotemporal dementia. J Geriatr Psychiatry Neurol.
25:146–154. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu JB, Zhou WH, Hu SH, Huang ML, Wei N, Qi
HL, Huang JW and Xu Y: Cross-cultural difference and validation of
the Chinese version of Montreal Cognitive Assessment in older
adults residing in Eastern China: Preliminary findings. Arch
Gerontol Geriatr. 56:38–43. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dong Y, Yean Lee W, Hilal S, Saini M, Wong
TY, Chen CL, Venketasubramanian N and Ikram MK: Comparison of the
Montreal Cognitive Assessment and the Mini-Mental State Examination
in detecting multi-domain mild cognitive impairment in a Chinese
sub-sample drawn from a population-based study. Int Psychogeriatr.
25:1831–1838. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Katzman R, Zhang MY, Ouang-Ya-Qu, Wang ZY,
Liu WT, Yu E, Wong SC, Salmon DP and Grant I: A Chinese version of
the Mini-Mental State Examination; impact of illiteracy in a
Shanghai dementia survey. J Clin Epidemiol. 41:971–978. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang D, Zheng J, Kurosawa M, Inaba Y and
Kato N: Changes in activities of daily living (ADL) among elderly
Chinese by marital status, living arrangement, and availability of
healthcare over a 3-year period. Environ Health Prev Med.
14:128–141. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang M, Zhu Z and Chen P: Community
investigation of the activities of daily living (ADL) and medical
conditions of the elderly in Shanghai. Zhonghua Yi Xue Za Zhi.
78:124–127. 1998.(In Chinese). PubMed/NCBI
|
|
31
|
Zheng YP, Zhao JP, Phillips M, Liu JB, Cai
MF, Sun SQ and Huang MF: Validity and reliability of the Chinese
Hamilton Depression Rating Scale. Br J Psychiatry. 152:660–664.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
López-Pousa S, Calvó-Perxas L, Lejarreta
S, Cullell M, Meléndez R, Hernández E, Bisbe J, Perkal H, Manzano
A, Roig AM, Turró-Garriga O, Vilalta-Franch J and Garre-Olmo J:
Registry of Dementias of Girona Study Group (ReDeGi Study Group):
Use of antidementia drugs in frontotemporal lobar degeneration. Am
J Alzheimers Dis Other Demen. 27:260–266. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Srikanth S, Nagaraja AV and Ratnavalli E:
Neuropsychiatric symptoms in dementia-frequency, relationship to
dementia severity and comparison in Alzheimer's disease, vascular
dementia and frontotemporal dementia. J Neurol Sci. 236:43–48.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Quaranta D, Marra C, Rossi C, Gainotti G
and Masullo C: Different apathy profile in behavioral variant of
frontotemporal dementia and Alzheimer's disease: A preliminary
investigation. Curr Gerontol Geriatr Res. 2012:7192502012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Broe M, Hodges JR, Schofield E, Shepherd
CE, Kril JJ and Halliday GM: Staging disease severity in
pathologically confirmed cases of frontotemporal dementia.
Neurology. 60:1005–1011. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Seeley WW: Selective functional, regional,
and neuronal vulnerability in frontotemporal dementia. Curr Opin
Neurol. 21:701–707. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Allman JM, Tetreault NA, Hakeem AY, Manaye
KF, Semendeferi K, Erwin JM, Park S, Goubert V and Hof PR: The von
Economo neurons in frontoinsular and anterior cingulate cortex in
great apes and humans. Brain Struct Funct. 214:495–517. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim EJ, Sidhu M, Gaus SE, Huang EJ, Hof
PR, Miller BL, DeArmond SJ and Seeley WW: Selective frontoinsular
von Economo neuron and fork cell loss in early behavioral variant
frontotemporal dementia. Cereb Cortex. 22:251–259. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Allman JM, Watson KK, Tetreault NA and
Hakeem AY: Intuition and autism: A possible role for Von Economo
neurons. Trends Cogn Sci. 9:367–373. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Moretti R, Torre P, Antonello RM, Cazzato
G and Bava A: Frontotemporal dementia: Paroxetine as a possible
treatment of behavior symptoms. A randomized, controlled, open
14-month study. Eur Neurol. 49:13–19. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lebert F, Stekke W, Hasenbroekx C and
Pasquier F: Frontotemporal dementia: A randomised, controlled trial
with trazodone. Dement Geriatr Cogn Disord. 17:355–359. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kril JJ, Macdonald V, Patel S, Png F and
Halliday GM: Distribution of brain atrophy in behavioral variant
frontotemporal dementia. J Neurol Sci. 232:83–90. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Taniguchi S, McDonagh AM, Pickering-Brown
SM, Umeda Y, Iwatsubo T, Hasegawa M and Mann DM: The neuropathology
of frontotemporal lobar degeneration with respect to the
cytological and biochemical characteristics of tau protein.
Neuropathol Appl Neurobiol. 30:1–18. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wei H, Dobkin C, Sheikh AM, Malik M, Brown
WT and Li X: The therapeutic effect of memantine through the
stimulation of synapse formation and dendritic spine maturation in
autism and fragile X syndrome. PLoS One. 7:e369812012. View Article : Google Scholar : PubMed/NCBI
|
